Geographic Variation in Epistaxis Interventions Among Medicare Beneficiaries

Abstract

Objectives: To quantify the utilization of epistaxis procedures in the elderly population and assess whether the geographic variability of these procedures is associated with hypertension and direct oral anticoagulant (DOAC) use. Methods: A cross-sectional study was performed on publicly available Medicare procedure and beneficiary data from 2013 to 2016 for all epistaxis procedures categorized by Common Procedural Terminology (CPT). Epistaxis procedures were analyzed by state, complexity, and provider type. Pearson’s correlation coefficient was calculated. Results: Over 4 years, 2 19 827 epistaxis procedures were performed on Medicare patients, 44.3% of which were categorized as simple (control of nasal hemorrhage: anterior simple or posterior primary). Otolaryngologists performed 92.6% of all epistaxis procedures. The frequency of epistaxis procedures performed by state ranged from 0.99 procedures per 10 000 Medicare beneficiaries (PP10K) in Hawaii to 25.7 PP10K in New Jersey. The percentage of epistaxis interventions categorized as complex (anterior complex, posterior subsequent, with nasal endoscopy, or open procedures) in each state varied from 0% in North Dakota to 72.6% in Hawaii. Epistaxis procedure utilization was weakly correlated with the prevalence of hypertension ( R2 = 0.08, P = .04) and higher percentage of DOAC among all anticoagulants prescribed ( R2 = 0.08, P = .04) in a state’s Medicare population. Utilization of complex epistaxis interventions was not correlated with the prevalence of hypertension or DOAC use. Conclusions: Otolaryngologists perform the vast majority of epistaxis procedures in the Medicare population. However, practice patterns vary across the United States. Hypertension and DOAC use are weakly associated with the utilization of epistaxis interventions.

Ambulatory visits for common rhinologic complaints in the United States: A patient‐centered perspective

“…7,8 This suggests appropriate selection of specialty care, as studies have shown that otolaryngologists perform the most epistaxis-related interventions in the Medicare population nationally. 6 Our data may further provide a lens with which to examine previously appreciated epidemiologic trends. Smith et al demonstrated regional variations in the treatment of chronic rhinosinusitis, with physicians in the Northeast ordering fewer diagnostic services and prescribing fewer medications per visit.…”

“…The only R‐RFVs that were seen most frequently by otolaryngologists were epistaxis and inflammation/swelling of the nose 7,8 . This suggests appropriate selection of specialty care, as studies have shown that otolaryngologists perform the most epistaxis‐related interventions in the Medicare population nationally 6 …”

“…It illuminates the variability of patient experience in a way that has not yet been described. 1,[3][4][5][6]…”